City officials warn federal vaccine schedule changes could complicate access; DOH vows local countermeasures

New York City health officials told the City Council on March 2, 2026, that recent federal changes to the pediatric vaccination schedule could undermine access and trust and that the city is stepping up local efforts to maintain coverage.

“There is no new scientific evidence to support the change in federal guidance,” said Dr. Martin, the city’s health commissioner, during a committee oversight hearing. He described the federal move to shift multiple vaccines into a shared clinical decision‑making framework as a potential source of confusion for families and clinicians and warned that insurers may stop covering doses not recommended by ACIP after insurer pledges expire.

Why it matters: The federal edits include a CDC recommendation that HPV receive only one dose (whereas New York City and state still advise two or three doses depending on age) and a January HHS memo that moved hepatitis A, meningococcal ACWY, hepatitis B birth dose, rotavirus, seasonal influenza, RSV and COVID‑19 toward individualized clinician‑patient decision making. Because the federal Vaccines for Children (VFC) program covers vaccines recommended by CDC/ACIP, those changes could affect which vaccines are supplied at no cost through federal channels and could create new administrative and financial burdens for providers and families.

DOH’s response: Dr. Martin described the city’s countermeasures: continuing to endorse the American Academy of Pediatrics schedule for children, reinforcing provider communications to more than 47,000 local clinicians, sustaining the VFC distribution network (about 2.5 million pediatric doses supplied annually), using the Citywide Immunization Registry (CIR) to target outreach and identify under‑vaccinated populations, and joining international and regional networks (including the WHO’s Global Outbreak Alert and Response Network and the Northeast Public Health Collaborative) to preserve data flow and situational awareness.

“We will adhere to the child and adolescent immunization schedule put forward by the American Academy,” Dr. Martin said, adding that the city is investing in community outreach and an approximately $1 million paid media campaign in multiple languages aimed at ZIP codes with low coverage.

Fiscal and operational risks: Cassandra Stewart of the New York City Independent Budget Office summarized an IBO report noting that the Division of Disease Control is heavily federally funded (about 70%) and that changes to what the CDC recommends could shift vaccine costs from federal programs to states, cities or patients. The IBO recommended continued monitoring and contingency planning.

Local experts and former federal officials urged active steps to protect coverage. “Vaccine misinformation is replacing scientific voices,” said Dr. Demetri Dascalis, a former CDC center director, who recommended strengthening local guidance, planning for funding disruptions and expanding community‑level education.

Council questions and next steps: Council members pressed DOH about practical impacts—whether insurer pledges (to cover previously recommended vaccines through 2026) will hold beyond 2026, how the VFC program and CIR will be used to prevent coverage gaps, and timelines for legislative proposals that would require DOH and DOE to produce public education materials. DOH told the committee it supports the intent of proposed local bills (Intro 260 and Intro 693) but wants to work with sponsors on reporting specifics and operational details.

The committee did not hold votes at the hearing; members signaled further oversight and budget scrutiny (including questions about how recently restored Article 6 public health funds will be spent). The council and DOH staff said they will continue to refine legislative language and implementation plans in follow‑ups.